FindTrial
Sign In

Establishment and implementation of cooperative management (CDTM) model of vancomycin for patients with renal insufficiency in intensive care department: a medical records based retrospective study

Establishment and implementation of cooperative management (CDTM) model of vancomycin for patients with renal insufficiency in intensive care department

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053628
Enrollment
Unknown
Registered
2021-11-26
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal insufficiency

Interventions

Observation group:None

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with renal insufficiency in intensive care; 2.Aged 12 to 80 years; 3.Indications for the use of vancomycin; 4.Patients participated voluntarily and signed the informed consent.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
Blood concentration of vancomycin;Vancomycin dose adjustment;Target concentration compliance rate;Incidence of adverse drug reactions;—

Secondary

MeasureTime frame
A preliminary evaluation of the therapeutic cooperative management model;—

Countries

China

Contacts

Public ContactWang Jinping

Shenzhen Second People's Hospital

787079848@qq.com+86 13928433600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026